# Dexmedetomidine Hydrochloride

NDC: 66794-235
Generic name: Dexmedetomidine Hydrochloride
Labeler / Manufacturer: Piramal Critical Care Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20210401

FDA application: ANDA209307

## Active ingredients

- DEXMEDETOMIDINE HYDROCHLORIDE: 4 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66794-235"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66794-235
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c958aeb4-69ce-c3e2-e053-2a95a90a6d8d